Catalyst
Slingshot members are tracking this event:
Novartis (NVS) Announces FDA Approval for Expanded Use of Illaris in Periodic Fever Syndrome Conditions
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda Approval, Expanded Use, Ilaris, Periodic Fever Syndrome Conditions
